From September 25th to September 26th the 6th European Forum on Extractables, Leachables, Medial Devices and Contact Materials Testing take place in Hamburg. The forum focuses on industry testing requirements for the identification and characterization of extractable, leachable (E&L), and non-intentionally added substances (NIAS) contaminants. Presentations from leaders in their field takes place over 2 days. On the 2nd day Dr. Heike Schmidt-Eisenlohr, expert for E&L studies at GBA Pharma Labs, presents a speech on ‘Extractable & Leachable Study with Integrity Testing & Toxicological Assessment’.

From September 25th to September 26th the 6th European Forum on Extractables, Leachables, Medial Devices and Contact Materials Testing take place in Hamburg. The forum focuses on industry testing requirements for the identification and characterization of extractable, leachable (E&L), and non-intentionally added substances (NIAS) contaminants. Presentations from leaders in their field takes place over 2 days. On the 2nd day Dr. Heike Schmidt-Eisenlohr, expert for E&L studies at GBA Pharma Labs, presents a speech on ‘Extractable & Leachable Study with Integrity Testing & Toxicological Assessment’.

The European Council agreed to a further extension of the date for the UK’s withdrawal from the EU at its meeting on 10-11 April. The extension will last as long as necessary and, in any event, no longer than 31 October 2019. EMA calls on all pharmaceutical companies to continue their preparedness for the UK’s withdrawal.